The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Reynolds Sells Fruity Vapes the FDA Never Authorized

Reynolds American, one of the largest US tobacco companies, is selling new fruit-flavored vaping products that the Food and Drug Administration has not authorized, according to STAT News. Under federal law, e-cigarettes must receive FDA marketing authorization before they can legally be sold, and the agency has denied or declined applications for most flavored products, citing their appeal to young people.

By pushing ahead without a green light, Reynolds is effectively daring regulators to act. A tobacco-nicotine expert told STAT the decision could spur other big manufacturers to launch unauthorized products too, betting that enforcement will be slow or inconsistent. That would widen a market already flooded with illegal disposable vapes, many imported from overseas, that the FDA and Customs have struggled to contain.

The episode highlights a persistent gap between the FDA's authority on paper and its capacity to enforce it. If a domestic giant faces no consequences, the agency's leverage over the entire nicotine market weakens.

Sources

More in Government

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.

Government

CMS Targets PBM Fees and MA Directory Accuracy in New Rule

CMS proposed a rule on Oct. 16 that would publicly score Medicare Advantage provider directories and mandate flat-fee payment structures for PBMs, with comments due Dec. 15.

Why it matters: Public directory scores and flat PBM fees would reshape how Medicare Advantage plans and drug middlemen operate and get paid.